Gracell Biotech boosts US IPO size to $209m

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Gracell Biotech boosts US IPO size to $209m

Jonathan Breen
January 08, 2021 08:30 AM
biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Gracell Biotechnologies has raised $209m from its Nasdaq IPO after increasing the size of the float and pricing the deal above the initial marketed range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityChinaAmericasCitiJefferies LLCAsiaGreater ChinaNortheast AsiaAsia PacificWells Fargo SecuritiesUnited StatesEmerging MarketsNorth AmericaSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article